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Critical events in the life cycle of herpes simplex virus (HSV) are the binding of cytoplasmic capsids to
cellular organelles and subsequent envelopment. Work from several laboratories suggests that these events
occur as a result of a network of partially redundant interactions among the capsid surface, tegument
components, and cytoplasmic tails of virally encoded glycoproteins. Consistent with this model, we previously
showed that tegument protein VP16 can speciﬁcally interact with the cytoplasmic tail of envelope protein gH
in vitro and in vivo when fused to glutathione S-transferase and to green ﬂuorescent protein, respectively. In
both instances, this association was strikingly temperature dependent: binding occurred only at 37°C and not
at lower temperatures. Here we demonstrate that virally expressed full-length gH and VP16 can be coimmu-
noprecipitated from HSV-infected cells and that this association is also critically dependent upon the physi-
ological temperature. To investigate the basis of this temperature requirement, we performed one- and
two-dimensional nuclear magnetic resonance spectroscopy on peptides with the sequence of the gH tail. We
found that the gH tail is disorganized at temperatures permissive for binding but becomes structured at lower
temperatures. Furthermore, a mutated tail unable to adopt this rigid conformation binds VP16 even at 4°C. We
hypothesize that the gH tail is unstructured under physiological conditions in order to maximize the number
of potential tegument partners with which it may associate. Being initially disordered, the gH tail may adopt
one of several induced conformations as it associates with VP16 or alternative components of the tegument,
maximizing redundancy during particle assembly.
Herpes simplex virus (HSV) type 1 (HSV-1) is an alphaher-
pesvirus with a 150-kb double-stranded genome packaged
within an icosahedral capsid. The capsid is surrounded by an
amorphous protein layer known as the tegument, which is in
turn surrounded by an envelope derived from host cell or-
ganelle membranes. Within the envelope are multiple virally
encoded glycoproteins, which function in many aspects of the
viral life cycle, such as host membrane attachment and fusion,
immune evasion, and prevention of apoptosis (23, 28). The
tegument is composed of at least 19 known viral polypeptide
species, which perform multiple functions during the life cycle
of the virus (28).
Several studies have indicated that viral envelopment and
tegumentation occur at late Golgi or post-Golgi compart-
ments, such as the trans-Golgi network and endosomes (4, 6,
15, 16, 23, 25, 31, 33). However, the molecular details that
drive envelopment are still poorly understood. It is thought
that a network of interactions among viral glycoproteins
present in the host organelle membranes, tegument proteins,
and capsid proteins is critical for this process. In this model,
tegument proteins serve as a bridge, binding to the cytoplasmic
tails of viral glycoproteins, each other, and capsid proteins,
thus recruiting capsids to the site of envelopment and allowing
capsids to bud into organelles. In support of this hypothesis,
several interactions were recently shown or suggested among
various tegument proteins (9, 10, 20, 22, 32), between the
tegument and glycoproteins (12, 36), and between the capsid
and the tegument (24, 35).
It appears that the web of interactions among the tegument
and glycoproteins is very redundant. For example, VP16 is
known to interact with VP22 (10) and Vhs (29, 32) as well as
gH (13, 36) and possibly gD and gB (36). Also, in pseudorabies
virus, tegument protein VP22 binds to both gM and gE (12),
and simultaneous deletion of both glycoproteins is required to
abrogate envelopment and prevent incorporation of VP22 into
mature viral particles (3). In HSV, simultaneous deletion of
several glycoprotein tails, such as gE, gI, and gD, is required in
order to appreciably affect viral egress and inhibit viral matu-
ration and envelopment (5, 11).
Previous work from our laboratory showed that VP16 inter-
acts with the cytoplasmic tail of gH both in vitro and in vivo
(13). In these experiments, VP16 could be speciﬁcally recov-
ered from infected cell extracts by using a glutathione S-trans-
ferase–gH tail fusion protein. Additionally, in cells transfected
with a construct expressing green ﬂuorescent protein (GFP)
fused to the gH tail and infected with wild-type HSV, anti-GFP
antibodies could be used to coimmunoprecipitate VP16. These
experiments also revealed that the interaction between VP16
and the gH carboxy terminus is temperature dependent, in that
binding took place only at the physiological temperature and
not at lower temperatures. Alanine scanning mutagenesis of
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6134the gH tail revealed that replacing a single proline residue at
the center of the tail with an alanine stimulated the binding of
VP16 to gH at 37°C and also relieved the temperature con-
straints of binding, allowing gH to interact with VP16 even at
4°C (13).
Here we report that virally expressed gH and VP16 can be
coimmunoprecipitated from HSV-infected cells, conﬁrming
our previous in vitro and in vivo data. As was found in our
earlier studies, this interaction is strikingly temperature depen-
dent, occurring only at 37°C. Furthermore, two-dimensional
(2D) nuclear magnetic resonance (NMR) analyses of synthetic
peptides with the sequence of the gH cytoplasmic tail reveal
that the temperature dependence of binding can be explained
by conformational changes in the tail. We propose that the gH
tail has evolved to be unstructured at a physiologically relevant
temperature in order to interact with multiple possible tegu-
ment partners during HSV assembly.
MATERIALS AND METHODS
Cells and viruses. COS7 or Vero cells were grown in Dulbecco’s modiﬁed
Eagle’s medium supplemented with 1% penicillin-streptomycin and 10% fetal or
newborn calf serum (GIBCO Laboratories), respectively. HSV strain SC16 was
prepared as previously described (7). gH-negative HSV-1 SC16 (SCgHZ) was
grown by infecting F6 complementing cell lines (stably expressing gH) (34) at a
multiplicity of 0.01 for 65 h at 37°C. Media and cells were harvested, concen-
trated, sonicated, divided into aliquots, and frozen. Virus was titrated on F6 cells.
Antibodies. Anti-VP16 monoclonal antibody 14-5 and goat anti-VP16 poly-
clonal antibody v-20 were obtained from Santa Cruz Biotechnology. Rabbit
anti-goat antibody (A-5420) and goat anti-rabbit immunoglobulin G (A-6154)
were obtained from Sigma.
Coimmunoprecipitation of full-length gH and VP16. Cells were infected with
HSV-1 strain SC16 or SCgHZ at a multiplicity of 10 or left uninfected. At 18 h
postinfection, postnuclear supernatants (PNS) were prepared as previously de-
scribed (15). Lysis buffer was added to each sample of PNS to ﬁnal concentra-
tions of 20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 0.5% NP-40, 0.5% EDTA, 0.5
mM phenylmethylsulfonyl ﬂuoride, 5 g/ml of leupeptin, 5 g/ml antipain, 2 mM
dithiothreitol, and 200 g/ml of bovine serum albumin, and the mixtures were
incubated for 30 min on ice. The resulting lysates were centrifuged for 15 min at
15,000  g and precleared by incubation with prewashed protein G-agarose
beads for 20 min at the temperature subsequently used for immunoprecipitation.
After the beads were pelleted for 20 s at 15,000  g, the supernatants were
collected and mixed with new protein G beads that had been preincubated with
mouse anti-VP16 monoclonal antibody for1ha t4°C. Incubation was performed
for 30 min at the appropriate temperature. After the beads were washed ﬁve
times with lysis buffer, bead-bound and unbound materials were subjected to
sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and
Western blotted with goat anti-VP16 and rabbit anti-gH antibodies as previously
described (13).
Synthesis of peptides with the sequences of the wild-type and proline-to-
alanine mutant gH tails. The sequences of the synthesized peptides were KVLR
TSVPFFWRRE, corresponding to the wild-type gH cytoplasmic tail, and KVLR
TSVAFFWRRE, corresponding to the proline-to-alanine (PA) mutant tail (13).
Peptides were synthesized on a 0.1-mmol scale by solid-phase peptide synthesis
with an ABI433A peptide synthesizer and a standard protocol (9-ﬂuorenyl-
methoxy carbonyl chemistry). Preloaded resin reagents piperidine, diisopropy-
lethylamine, N-methylpyrrolidone, dichloromethane, and 9-ﬂuorenylmethoxy
carbonyl amino acids and an hydroxybenzotriazole activation kit were purchased
from Applied Biosystems. Peptide resins were cleaved and deprotected by using
a mixture of triﬂuoroacetic acid, thioamisole, ethanedithiol, phenol, and water
for 2 h. Peptides were precipitated with ether and washed.
Peptides were characterized by matrix-assisted laser desorption ionization–
time-of-ﬂight mass spectroscopy with a Perspective Biosystems Voyager DE as
well as by analytical high-pressure liquid chromatography (HPLC) with a C8
reverse-phase column (2.1 by 250 mm) on a Hewlett-Packard HPLC 1090 in-
strument. Amino acid analysis was performed with a Hewlett-Packard Amino
Quant HPLC system. Peptides were puriﬁed by HPLC with 1-cm C18 reverse-
phase columns and dissolved in phosphate buffer to ﬁnal concentrations of 2.7
mM peptide in 15 mM phosphate buffer at pH 6.1 (for the wild-type gH tail
peptide) and 0.14 mM peptide in 20 mM phosphate buffer at pH 6.0 (for the PA
mutant gH tail peptide).
NMR spectroscopy of wild-type and mutant gH peptides. All NMR spectra
were recorded at 600 MHz on a Bruker DRX600 spectrometer.
1H chemical
shifts were referenced to an internal 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid
standard at 0 ppm. Standard methods were used to obtain homonuclear DQF-
COSY (30), TOCSY (2, 27), and NOESY (17) spectra for wild-type gH and PA
peptides at 10°C and 37°C in 90% H2O and 10% D2O. The TOCSY spectra were
acquired with spin-lock periods of 42 and 100 ms, and the NOESY spectra were
obtained with 300-ms mixing times. For all 2D spectra, 32 scans were collected.
The spectra were acquired with 4,096 complex data points in the direct dimen-
sion and 680 points in the indirect dimension, with a spectral width of 14 ppm
(8,389 Hz) in both dimensions.
The one-dimensional (1D) spectra of the wild-type gH and PA peptides were
collected at a series of temperatures ranging from 2 to 45°C in approximately 5°
increments. 1D spectra for the wild-type gH peptide were acquired with 64 scans,
for the PA peptide 1,000 scans were collected, and for both wild-type gH and PA
peptides spectra were obtained with 2,048 complex data points. The temperature
dependence of every identiﬁable resonance was monitored.
The spectra were processed by using NMRPipe (8) and analyzed by using the
NMRView program (18). All structural calculations were performed by using
DYANA version 1.5 (14) and MOLMOL (21). Coupling constants were measured
by using the XEASY computer program (1). The Karplus equation (19) was used to
derive  angle constraints from the measured coupling constants. Distance con-
straints were derived from NOE cross-peak intensities within NMRView and
corrected for pseudoatoms and methyl intensities within DYANA.
RESULTS
Coimmunoprecipitation of full-length gH and VP16. In our
previous studies, we were able to show that VP16 and the gH
tail interact in vivo, using a fusion protein between GFP and
the gH tail (13). To deﬁnitively establish that VP16 and gH
interact in the context of an authentic in vivo infection, we
attempted to coimmunoprecipitate full-length VP16 and gH
from infected cells. We prepared PNS from cells infected with
either SC16 (a wild-type strain of HSV) or SCgHZ (a gH-
negative strain of HSV) or from cells that were left uninfected.
The PNS were treated with salt and detergent as outlined in
the Materials and Methods to release gH and VP16 from
membranes and virus particles. The lysates were then cleared
by centrifugation, and incubated with prewashed Protein G
beads to minimize background binding. These precleared ly-
sates were then incubated with fresh Protein G beads that were
either untreated or precoated with a monoclonal antibody di-
rected against VP16. Immunoprecipitation was then allowed to
occur at 37°C or other temperatures. Material that was immu-
noprecipitated with the beads as well as that remaining un-
bound was subjected to SDS-PAGE, and then Western blotted
with polyclonal anti-VP16 or anti-gH antibodies (Fig. 1).
VP16 was immunoprecipitated from the PNS lysates when
incubated with beads that were coated with anti-VP16 anti-
body (Fig. 1, top panel, lanes 4 and 6), but not with untreated
control beads (lanes 5 and 7), nor from mock-infected cell
extracts (lane 8). The lower panel in Fig. 1 shows the Western
blot with anti-gH antibody. In lane 4, which corresponds to
material immunoprecipitated from wild-type HSV-infected
cell lysates using anti-VP16 antibody, a band was visible at
110 kDa, corresponding to the molecular weight of gH. This
band disappeared when anti-VP16 antibodies were omitted
(Fig. 1, lane 5, lower panel) or when the infecting virus was a
gH-null strain (lanes 6 and 7, lower panel). These data imply
that full-length gH can be coimmunoprecipitated with VP16,
suggesting the two polypeptides interact in infected cells, con-
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(36). In control experiments, gC was found to not speciﬁcally
coimmunoprecipitate with anti-VP16 antibodies, showing that
gH is not recovered as part of a “bulk” incompletely solubilized
envelope fraction. Nevertheless, we cannot discount the pos-
sibility that other envelope and tegument components may be
speciﬁcally associated with the VP16/gH complex, and we are
currently examining this possibility.
Temperature dependence of VP16/gH interaction. In our
previous studies we found that binding of gH to VP16 was
temperature dependent –binding was detectable within 1 h
when incubations were conducted at 37°C, but not at room
temperature or 4°C (13). We wanted to test whether the in vivo
binding of full-length gH and VP16 was similarly dependent on
temperature. Figure 2 shows a series of immunoprecipitation
reactions incubated at different temperatures with lysates from
SC16-infected cells in the presence (lanes 2, 4, 6, 8, 10, and 12)
or absence (lanes 3, 5, 7, 9, 11, and 13) of VP16 antibody. As
with the previous experiment, material that was bound (Fig. 2,
lanes 2 to 7) or unbound (lanes 8 to 13) to the beads, and the
initial cell lysate (lane 1) were subjected to SDS-PAGE and
Western blotted for VP16 and gH. Consistent with previous in
vitro and in vivo ﬁndings, full-length gH only coimmunopre-
cipitated with VP16 at 37°C but not at room temperature or
4°C.
The striking temperature dependence of VP16/gH associa-
tion, suggested the possibility that some temperature-depen-
dent biochemical modiﬁcation of VP16, or of other polypep-
tides in the extract, may be a prerequisite for interaction with
the gH tail. However, preincubation of infected cell extracts at
37°C did not permit subsequent binding of VP16 to glutathione
S-transferase–gH at 4°C (data not shown), implying that if such
modiﬁcations occur, they are reversed at 4°C or require the
simultaneous presence of the gH tail.
As an alternative, we considered the possibility that the
temperature dependence of binding might result from confor-
FIG. 1. Coimmunoprecipitation of gH and VP16 from infected cells. Cell lysates were prepared from cells infected with HSV (wild type [WT])
or gH-null HSV (gH) or from uninfected cells (U). Lysates were incubated () or not incubated () with mouse anti-VP16 monoclonal antibody
at 37°C. Total cell lysates (CL: lanes 1 to 3), immunoprecipitated (bound) material (lanes 4 to 8), and unbound material (lanes 9 to 13) were
subjected to SDS-PAGE, Western blotted, and probed with anti-gH and anti-VP16 antisera as indicated at the left. Positions and masses (in
kilodaltons) of molecular mass markers are indicated by arrows. Note that 1/10 the total unbound material was run on the gels.
FIG. 2. Temperature dependence of VP16/gH coimmunoprecipitation. Coimmunoprecipitation experiments were performed as described in
the legend to Fig. 1, except that incubation was done at 37°C, room temperature (RT), or 4°C. Western blotting was performed with total cell
lysates (CL: lane 1) as well as bound (lanes 2 to 7) and unbound (lanes 8 to 13) material as described in the legend to Fig. 1. Note that 1/10 the
total unbound material was run on the gels.
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tion of gH at 37°C is compatible with VP16 binding, but at
reduced temperatures the tail undergoes conformational
changes which preclude its association with VP16. Since our
previous studies have shown that mutation of the proline res-
idue in the center of the tail permits VP16 binding even at 4°C
(13), this hypothesis predicts that the mutant tail would be in
the binding-permissive conformation at all temperatures. To
test our hypothesis, we examined the structural properties of
peptides corresponding to the cytoplasmic tails of wild-type gH
and the PA mutant.
Conformation of gH C-terminal peptides. We used 1D and
2D NMR spectroscopy to characterize the temperature-depen-
dent conformations of peptides corresponding to the C-termi-
nal segments of wild-type (KVLRTSVPFFWRRE) and PA
mutant gH (KVLRTSVAFFWRRE), beginning with the wild-
type sequence at low temperature. 2D homonuclear DQF-
COSY, TOCSY, and NOESY NMR spectra were used to
assign the resonances of the peptide at 10°C. Figure 3A shows
the ﬁngerprint region of a 2D TOCSY spectrum. This exper-
iment allows one to correlate, through scalar coupling, most or
all of the protons in the spin system of a given residue. This
region of the spectrum is particularly useful because the direct
dimension represents the amide proton chemical shift, and the
indirect dimension shows a set of cross-peaks to all other
scalar-coupled protons in the side chain. One observes a single
set of correlations for each amino acid except proline. Using
these data, we were able to assign a residue type to each amide,
and hence identify all the amino acid types in the peptide. A
few cross-peaks in the TOCSY spectrum remained unassigned;
these cross-peaks likely arise from contaminants from the pep-
tide synthesis, and did not affect the analysis. A 2D DQF-
COSY, which exclusively correlates protons on neighboring
carbon or nitrogen nuclei via
3JH-H scalar coupling, was used to
unambiguously assign all side chain protons, including those of
Pro8 (the single proline in the tail, lying close to the center of
the sequence) which do not appear in the ﬁngerprint region of
the TOCSY spectrum.
A 2D NOESY experiment was used to make sequence-
speciﬁc assignments. Figure 3B shows the
1H
N-
1H
 region of
the NOESY spectrum. Each cross-peak occurs at either the
chemical shift of the
1H
N
i-
1H

i or the
1H
N
i-
1H

I1, where i
represents an amino acid residue in the sequence. The
1H
N-
1H
 chemical shifts of Thr5 and Ser6 are also seen in this
region, but are not used in the assignment process. Connec-
tions between amino acids that are adjacent in sequence are
indicated in Fig. 3B. Several resonances were overlapped, in-
cluding Leu3 and Arg4, Val2 and Arg13, and Thr5, and Val7
and Phe9, but it was still possible to make connections between
resonances, and hence the sequence-speciﬁc assignments.
Most observed NOEs were intraresidue or short-range be-
tween adjacent residues. However, a signiﬁcant number of
longer medium-range NOEs were observed in the central re-
gion of the peptide, between protons in residues 5 through 10
(Fig. 4). Figure 4A illustrates NOEs between residues 8 and 5
and residues 10 and 7, with additional NOEs between residues
10 and 7 and residues 9 and 7 visible in Fig. 4B and C. A total
of 113 intraresidue, 47 interresidue, and 21 medium-range
NOEs were used to derive distance constraints for structure
calculations.
3JN coupling constants were measured and
FIG. 3. 2D NMR spectra of wild-type gH peptide. (A) 2D TOCSY
spectrum highlighting the amide side-chain correlations. Assignments of
residue and atom types are shown. (B)
1H
N-
1H
 region of the NOESY
spectrum. The sequence-speciﬁc connections are indicated by red lines.
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11 to 14. For the structure calculation, these angles were
loosely deﬁned as falling in the range of 35° to 175°.
NMR structural models for the gH peptide at 10°C were
calculated by using the program DYANA (14). Residues 4
through 10 of the nine lowest-energy structures are shown in
Fig. 5. All distance constraints were satisﬁed to within 0.8 Å,
and all angle constraints were satisﬁed to within 5°. The root
mean square deviations between backbone atoms for this seg-
ment was 0.9 Å. Residues 1 to 3 and residues 11 to 14 appeared
highly disordered, as expected for the ends of a peptide, and
hence are not shown. The side chains of residues 7, 8, and 10
are highlighted in green in Fig. 5. Several NOEs were observed
between residues 7 and 10 (Fig. 4). It is noteworthy that this
small region of stable structure is centered around Pro8, the
residue whose mutation to alanine eliminates the temperature
dependence of peptide binding to VP16 (13).
Temperature dependence of wild-type and mutant gH pep-
tide conformations. We next investigated whether any tem-
perature-dependent structural differences existed between
the two peptides. We were unable to determine a structure
of the wild-type peptide at 37°C due to the scarcity of NOEs
(indicating a lack of structure), and the low solubility of the
PA mutant precluded 2D NMR measurements at any tem-
perature. We therefore examined the temperature depen-
dence of the 1D
1H NMR spectra for both peptides. Figure
FIG. 4. Expansions of the NOESY spectrum of wild-type gH peptide showing medium-range NOEs. The regions shown are NOEs between the
side chains of Thr5 and Pro8 and of Val7 and Phe10 (A), the amide of Phe10 and the side chain of Val7 (B), and ring protons of Phe10 and the
side chain of Val7 (C).
FIG. 5. Structural model of wild-type gH tail peptide at 10°C. The nine lowest-energy structures are superimposed. Residues 1 to 3 and residues
11 to 14 are highly disordered and were omitted for clarity. The backbone is colored blue, and the side chains are colored red, with the exception
of those of Val7, Pro8, and Phe10, which are highlighted in green.
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phatic proton resonances for both peptides at a series of
temperatures. In the wild-type peptide, a number of reso-
nances shift with temperature (Fig. 6A). Figure 6C shows
the temperature proﬁles of side chain resonances for resi-
dues 4, 8, and 10. The chemical shift changes with respect to
temperature were sigmoidal, suggesting a cooperative ther-
mal transition that corresponds to a loss of stable structure
in the wild-type peptide. Interestingly, there was very little
to no temperature dependence of the chemical shifts in the
PA mutant (Fig. 6B), suggesting that the PA mutant has no
stable structure at any temperature examined. Note that the
proﬁle of the (unstructured) wild-type peptide at the higher
temperatures is expected to be similar, but not identical, to
that of the mutant peptide. This is because in the PA mutant
one loses the signals for the proline, gains signals from the
new alanine, and the signals of the two amino acids sur-
rounding the mutation (one on each side) will shift at least
slightly as a result of being chemically bonded to a different
residue type.
FIG. 6. Temperature dependence of aliphatic proton NMR resonances in wild-type and mutant gH peptides. (A) 1D
1H NMR spectra of
wild-type (WT) gH peptide recorded from 2°C (bottom) to 45°C (top). The red lines indicate a signiﬁcant change in chemical shift with
temperature. (B) 1D
1H NMR spectra of gH PA mutant peptide recorded from 2 to 40°C. The red lines indicate little to no change in chemical
shift with temperature. (C) Temperature proﬁles of three individual resonances (Arg4, Pro8, and Phe10, indicated in the single-letter amino acid
code) of the wild-type gH peptide indicating cooperative changes with temperature.
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In our previous studies we have shown that VP16 and the gH
cytoplasmic tail interact, and that the binding was strikingly
affected by temperature, both in vitro and in vivo (13). Here we
have conﬁrmed the in vivo binding of full-length gH and VP16,
and shown that it exhibits similar temperature dependence to
our in vitro assay system. The observation that mutation of the
central proline residue (Pro8) to alanine relieved this temper-
ature dependence prompted us to test the effects of tempera-
ture on the conformation of synthetic peptides with the se-
quence of the gH cytoplasmic tail.
The solution conformations of the gH peptide exhibited
several interesting features. We ﬁrst attempted to determine
the structure at 37°C, but very few NOEs were observed in
either NOESY or ROESY spectra, indicating that the peptide
is dynamic and unstructured at this temperature. We were able
to determine the structure at 10°C. A number of obvious me-
dium-range NOEs were observed between protons of residues
5 through 10, including several between protons of Val7 and
Phe10. These two residues are in close van der Waals contact
in the resulting structural models. This results in a tight turn of
the peptide backbone, facilitated by Pro8. There is also a
distinct NOE between the 	1 proton of Pro8 and the 
 proton
of Thr5. The absence of a NOE involving the 	2 proton sug-
gests that the backbone is in a speciﬁc, stable structure. We
propose that this small amount of stable structure is what
inhibits binding to VP16 at temperatures lower that 37°C. At
37°C, the energy of thermal ﬂuctuations is greater than the
energy of the intramolecular interactions, and therefore the
structure is destabilized. This is consistent with an induced ﬁt
mechanism in which the peptide must be unstructured in order
to bind VP16. Any preformed structure inhibits binding.
This idea is supported by the fact that the PA mutant can
bind at any temperature studied. A proline can restrict the
conformation of a peptide. This in turn would reduce the
conformational entropy contribution to the Gibbs free energy,
hence allowing the enthalpy term to make a greater contribu-
tion. Thus, a few relatively weak interactions could result in the
stabilization of a structure when a proline is present. Con-
versely, as in this situation, substitution of a proline with ala-
nine increases the entropy and destabilizes the peptide struc-
ture. We attempted to determine the structure of the PA
mutant at 10°C but were unsuccessful. The PA mutant is much
less soluble than the wild-type peptide and yielded very weak
NMR signals. Hence, we carried out a series of 1D
1H NMR
experiments at temperatures varying from 2 to 40°C (Fig. 6). If
one looks carefully at the wild-type peptide data, it is apparent
that several resonances shift with temperature. Closer inspec-
tion reveals that the temperature proﬁles of individual reso-
nances have a sigmoidal shape, typical of a cooperative dena-
turation curve. On the contrary, in the PA NMR spectrum, it
is apparent that the resonances in the same spectral region
have very little to no temperature dependence. This suggests
that the mutant peptide does not contain the structure that is
present in the wild-type peptide.
In summary, we have demonstrated that at 10°C a small
segment of the gH peptide is structured. As the temperature is
increased, this structure denatures. It is the loss of this struc-
ture that facilitates the peptide binding to VP16. The presence
of the proline at position eight is a major contributor to the
stability of this structure, and hence, if one mutates this proline
to alanine, the structure is completely destabilized and the
peptide binds freely at all temperatures.
The residues involved in the conformational transitions, as
identiﬁed by sequential 1D NMR spectra, are remarkably con-
sistent with the ﬁndings of our previous mutagenesis study
(13). These residues include the leucine at position 3, the
proline at position 8, the phenylalanine at position 10, the
tryptophan at position 11, the glutamic acid residue at position
14, and to a more limited extent the arginine at position 13.
These residues have all been shown to be involved in VP16
binding, either by promoting binding (Leu3, Phe10, Trp11, and
Arg13) or by interfering with it (Pro8 and Glu14) (13).
It is becoming increasingly clear that HSV particle assembly
is a process with a great deal of inherent redundancy (3, 11, 12,
26). The fact that the gH cytoplasmic tail must be unstructured
in order to bind VP16 suggests one mechanism by which such
redundancy may be achieved. We hypothesize that gH may
bind VP16 via an “induced-ﬁt” mechanism, wherein the tail
must be malleable and unstructured before binding in order to
assume a speciﬁc conformation upon interaction with VP16
but perhaps an alternative conformation when binding other
tegument components. In this way, the gH tail can select from
an array of possible binding partners, Such ﬂexibility would
maximize the efﬁciency with which viral structural components
are assembled into the maturing particle.
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